Direct costs to private insurers of diversion of medications for attention-deficit/hyperactivity disorder

Aldridge, A., Kroutil, L., Cowell, A., Reeves, D., & Van Brunt, D. (2011). Direct costs to private insurers of diversion of medications for attention-deficit/hyperactivity disorder. PharmacoEconomics, 29(7)(1170-7690), 621 - 635.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Validation of a brief internalized sex-work stigma scale among female sex workers in Kenya
Article

Defining the social determinants of health for nursing action to achieve health equity
Article

Incorporating qualitative research methods into the monitoring and evaluation of neglected tropical disease programmes